- Home
- CRF vs EMBC Comparison
CRF vs EMBC Comparison
Compare CRF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRF
- EMBC
- Stock Information
- Founded
- CRF 1973
- EMBC 1924
- Country
- CRF United States
- EMBC United States
- Employees
- CRF N/A
- EMBC N/A
- Industry
- CRF Finance/Investors Services
- EMBC Medical/Dental Instruments
- Sector
- CRF Finance
- EMBC Health Care
- Exchange
- CRF Nasdaq
- EMBC Nasdaq
- Market Cap
- CRF 926.5M
- EMBC 1.0B
- IPO Year
- CRF N/A
- EMBC N/A
- Fundamental
- Price
- CRF $7.54
- EMBC $13.00
- Analyst Decision
- CRF
- EMBC Buy
- Analyst Count
- CRF 0
- EMBC 2
- Target Price
- CRF N/A
- EMBC $19.00
- AVG Volume (30 Days)
- CRF 1.5M
- EMBC 675.6K
- Earning Date
- CRF 01-01-0001
- EMBC 05-08-2025
- Dividend Yield
- CRF 17.55%
- EMBC 4.72%
- EPS Growth
- CRF N/A
- EMBC 2.96
- EPS
- CRF 1.40
- EMBC 0.99
- Revenue
- CRF $11,461,786.00
- EMBC $1,107,700,000.00
- Revenue This Year
- CRF N/A
- EMBC N/A
- Revenue Next Year
- CRF N/A
- EMBC $0.99
- P/E Ratio
- CRF $5.50
- EMBC $12.84
- Revenue Growth
- CRF 6.53
- EMBC N/A
- 52 Week Low
- CRF $6.52
- EMBC $9.93
- 52 Week High
- CRF $9.75
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- CRF 31.71
- EMBC 35.90
- Support Level
- CRF $7.50
- EMBC $12.51
- Resistance Level
- CRF $7.75
- EMBC $14.46
- Average True Range (ATR)
- CRF 0.27
- EMBC 0.81
- MACD
- CRF -0.02
- EMBC 0.17
- Stochastic Oscillator
- CRF 10.84
- EMBC 36.80
About CRF Cornerstone Total Return Fund Inc. (The)
Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology; Health Care; Financials; Communication Services; Consumer Discretionary; Industrials; Exchange-Traded Funds; Utilities; Energy; Real Estate and others.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.